Logo image of CRTO

CRITEO SA-SPON ADR (CRTO) Stock Fundamental Analysis

USA - NASDAQ:CRTO - US2267181046 - ADR

19.8 USD
-0.44 (-2.17%)
Last: 10/16/2025, 4:00:43 PM
19.8 USD
0 (0%)
After Hours: 10/16/2025, 4:00:43 PM
Fundamental Rating

6

Taking everything into account, CRTO scores 6 out of 10 in our fundamental rating. CRTO was compared to 95 industry peers in the Media industry. CRTO gets an excellent profitability rating and is at the same time showing great financial health properties. CRTO is valued quite cheap, but it does not seem to be growing. With these ratings, CRTO could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CRTO had positive earnings in the past year.
In the past year CRTO had a positive cash flow from operations.
Each year in the past 5 years CRTO has been profitable.
Each year in the past 5 years CRTO had a positive operating cash flow.
CRTO Yearly Net Income VS EBIT VS OCF VS FCFCRTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

CRTO has a Return On Assets of 6.46%. This is amongst the best in the industry. CRTO outperforms 83.16% of its industry peers.
CRTO's Return On Equity of 12.54% is fine compared to the rest of the industry. CRTO outperforms 77.89% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.68%, CRTO belongs to the top of the industry, outperforming 88.42% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRTO is below the industry average of 8.50%.
The last Return On Invested Capital (10.68%) for CRTO is above the 3 year average (5.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.46%
ROE 12.54%
ROIC 10.68%
ROA(3y)2.5%
ROA(5y)3.63%
ROE(3y)5.48%
ROE(5y)6.88%
ROIC(3y)5.66%
ROIC(5y)6.99%
CRTO Yearly ROA, ROE, ROICCRTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a decent Profit Margin value of 7.02%, CRTO is doing good in the industry, outperforming 74.74% of the companies in the same industry.
CRTO's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 9.54%, CRTO is doing good in the industry, outperforming 61.05% of the companies in the same industry.
In the last couple of years the Operating Margin of CRTO has grown nicely.
CRTO's Gross Margin of 52.85% is fine compared to the rest of the industry. CRTO outperforms 62.11% of its industry peers.
In the last couple of years the Gross Margin of CRTO has grown nicely.
Industry RankSector Rank
OM 9.54%
PM (TTM) 7.02%
GM 52.85%
OM growth 3Y0.28%
OM growth 5Y3.86%
PM growth 3Y-1.1%
PM growth 5Y7.55%
GM growth 3Y13.6%
GM growth 5Y6.76%
CRTO Yearly Profit, Operating, Gross MarginsCRTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRTO is still creating some value.
The number of shares outstanding for CRTO has been reduced compared to 1 year ago.
Compared to 5 years ago, CRTO has less shares outstanding
Compared to 1 year ago, CRTO has a worse debt to assets ratio.
CRTO Yearly Shares OutstandingCRTO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRTO Yearly Total Debt VS Total AssetsCRTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.35 indicates that CRTO is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.35, CRTO is doing good in the industry, outperforming 73.68% of the companies in the same industry.
CRTO has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
CRTO has a better Debt to FCF ratio (0.07) than 91.58% of its industry peers.
CRTO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, CRTO belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 2.35
ROIC/WACC1.31
WACC8.13%
CRTO Yearly LT Debt VS Equity VS FCFCRTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

CRTO has a Current Ratio of 1.23. This is a normal value and indicates that CRTO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.23, CRTO perfoms like the industry average, outperforming 53.68% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that CRTO should not have too much problems paying its short term obligations.
CRTO's Quick ratio of 1.23 is in line compared to the rest of the industry. CRTO outperforms 53.68% of its industry peers.
CRTO does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
CRTO Yearly Current Assets VS Current LiabilitesCRTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.09% over the past year.
CRTO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.28% yearly.
Looking at the last year, CRTO shows a decrease in Revenue. The Revenue has decreased by -0.55% in the last year.
Measured over the past years, CRTO shows a decrease in Revenue. The Revenue has been decreasing by -3.09% on average per year.
EPS 1Y (TTM)15.09%
EPS 3Y10.74%
EPS 5Y11.28%
EPS Q2Q%-14.81%
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y-4.99%
Revenue growth 5Y-3.09%
Sales Q2Q%9.35%

3.2 Future

CRTO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.68% yearly.
Based on estimates for the next years, CRTO will show a small growth in Revenue. The Revenue will grow by 4.46% on average per year.
EPS Next Y0.23%
EPS Next 2Y1.59%
EPS Next 3Y4.68%
EPS Next 5YN/A
Revenue Next Year4.83%
Revenue Next 2Y3.33%
Revenue Next 3Y4.46%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRTO Yearly Revenue VS EstimatesCRTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CRTO Yearly EPS VS EstimatesCRTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

8

4. Valuation

4.1 Price/Earnings Ratio

CRTO is valuated cheaply with a Price/Earnings ratio of 4.19.
92.63% of the companies in the same industry are more expensive than CRTO, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.53, CRTO is valued rather cheaply.
CRTO is valuated cheaply with a Price/Forward Earnings ratio of 4.18.
CRTO's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRTO is cheaper than 91.58% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CRTO to the average of the S&P500 Index (23.04), we can say CRTO is valued rather cheaply.
Industry RankSector Rank
PE 4.19
Fwd PE 4.18
CRTO Price Earnings VS Forward Price EarningsCRTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CRTO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CRTO is cheaper than 95.79% of the companies in the same industry.
84.21% of the companies in the same industry are more expensive than CRTO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.32
EV/EBITDA 2.89
CRTO Per share dataCRTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CRTO has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)17.94
PEG (5Y)0.37
EPS Next 2Y1.59%
EPS Next 3Y4.68%

0

5. Dividend

5.1 Amount

No dividends for CRTO!.
Industry RankSector Rank
Dividend Yield N/A

CRITEO SA-SPON ADR

NASDAQ:CRTO (10/16/2025, 4:00:43 PM)

After market: 19.8 0 (0%)

19.8

-0.44 (-2.17%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners93.23%
Inst Owner Change-3.3%
Ins Owners2.21%
Ins Owner Change-0.53%
Market Cap1.04B
Analysts80
Price Target38.67 (95.3%)
Short Float %0.95%
Short Ratio1.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.83%
Min EPS beat(2)27.81%
Max EPS beat(2)39.85%
EPS beat(4)4
Avg EPS beat(4)27.08%
Min EPS beat(4)13.45%
Max EPS beat(4)39.85%
EPS beat(8)8
Avg EPS beat(8)28.62%
EPS beat(12)11
Avg EPS beat(12)26.87%
EPS beat(16)15
Avg EPS beat(16)29.4%
Revenue beat(2)2
Avg Revenue beat(2)1.94%
Min Revenue beat(2)0.02%
Max Revenue beat(2)3.86%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-2.28%
Max Revenue beat(4)3.86%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)9
Avg Revenue beat(12)16.96%
Revenue beat(16)13
Avg Revenue beat(16)45.69%
PT rev (1m)-3.25%
PT rev (3m)-9.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.85%
EPS NY rev (1m)1.23%
EPS NY rev (3m)2.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.62%
Valuation
Industry RankSector Rank
PE 4.19
Fwd PE 4.18
P/S 0.53
P/FCF 5.32
P/OCF 3.6
P/B 0.95
P/tB 2.63
EV/EBITDA 2.89
EPS(TTM)4.73
EY23.89%
EPS(NY)4.74
Fwd EY23.92%
FCF(TTM)3.72
FCFY18.79%
OCF(TTM)5.51
OCFY27.81%
SpS37.19
BVpS20.81
TBVpS7.53
PEG (NY)17.94
PEG (5Y)0.37
Profitability
Industry RankSector Rank
ROA 6.46%
ROE 12.54%
ROCE 14.49%
ROIC 10.68%
ROICexc 12.94%
ROICexgc 37.78%
OM 9.54%
PM (TTM) 7.02%
GM 52.85%
FCFM 10%
ROA(3y)2.5%
ROA(5y)3.63%
ROE(3y)5.48%
ROE(5y)6.88%
ROIC(3y)5.66%
ROIC(5y)6.99%
ROICexc(3y)7.72%
ROICexc(5y)10.78%
ROICexgc(3y)32.11%
ROICexgc(5y)32.74%
ROCE(3y)7.68%
ROCE(5y)9.49%
ROICexcg growth 3Y7.88%
ROICexcg growth 5Y9.99%
ROICexc growth 3Y-10.63%
ROICexc growth 5Y-2.72%
OM growth 3Y0.28%
OM growth 5Y3.86%
PM growth 3Y-1.1%
PM growth 5Y7.55%
GM growth 3Y13.6%
GM growth 5Y6.76%
F-Score8
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0
Cap/Depr 91.41%
Cap/Sales 4.8%
Interest Coverage 142.98
Cash Conversion 100.1%
Profit Quality 142.58%
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 2.35
F-Score8
WACC8.13%
ROIC/WACC1.31
Cap/Depr(3y)101.15%
Cap/Depr(5y)85.42%
Cap/Sales(3y)4.7%
Cap/Sales(5y)3.96%
Profit Quality(3y)756.67%
Profit Quality(5y)511.62%
High Growth Momentum
Growth
EPS 1Y (TTM)15.09%
EPS 3Y10.74%
EPS 5Y11.28%
EPS Q2Q%-14.81%
EPS Next Y0.23%
EPS Next 2Y1.59%
EPS Next 3Y4.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.55%
Revenue growth 3Y-4.99%
Revenue growth 5Y-3.09%
Sales Q2Q%9.35%
Revenue Next Year4.83%
Revenue Next 2Y3.33%
Revenue Next 3Y4.46%
Revenue Next 5YN/A
EBIT growth 1Y23.58%
EBIT growth 3Y-4.73%
EBIT growth 5Y0.65%
EBIT Next Year228.62%
EBIT Next 3Y52.1%
EBIT Next 5Y29.59%
FCF growth 1Y144.23%
FCF growth 3Y2.77%
FCF growth 5Y7.59%
OCF growth 1Y36.93%
OCF growth 3Y5.33%
OCF growth 5Y2.99%